|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,155.40 INR | -0.13% |
|
-0.35% | +26.32% |
| Market Cap | 1,154B 11.99B 10.49B 9.67B 8.89B 16.85B 17.14B 115B 45.31B 564B 45.04B 44.05B 1,944B | P/E 2027 * |
27.4x | P/E 2028 * | 23.5x |
|---|---|---|---|---|---|
| Enterprise Value | 1,238B 12.86B 11.25B 10.38B 9.54B 18.07B 18.38B 124B 48.6B 605B 48.31B 47.25B 2,085B | EV / Sales 2027 * |
4.04x | EV / Sales 2028 * | 3.57x |
| Free-Float |
24.82% | Yield 2027 * |
0.57% | Yield 2028 * | 0.59% |
Last Transcript: Zydus Lifesciences Limited
| 1 day | -0.16% | ||
| 1 week | -0.35% | ||
| Current month | +3.81% | ||
| 1 month | +7.07% | ||
| 3 months | +22.99% | ||
| 6 months | +33.05% | ||
| Current year | +26.32% |
| 1 week | 1,126.6 |  | 1,169.7 |
| 1 month | 1,053.8 | | 1,181.5 |
| Current year | 835.5 | | 1,181.5 |
| 1 year | 835.5 | | 1,181.5 |
| 3 years | 567.75 | | 1,324.3 |
| 5 years | 319 | | 1,324.3 |
| 10 years | 202 | | 1,324.3 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 47 | 27/11/2009 | |
| Director of Finance/CFO | 65 | - | |
| Director of Finance/CFO | 56 | 01/09/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 47 | 01/04/2007 | |
| Director/Board Member | 71 | 01/08/1997 | |
| Chairman | 71 | 05/10/2011 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.13% | -0.35% | +19.21% | +91.53% | 11.99B | |
| -0.07% | +0.58% | +14.64% | +80.96% | 48.66B | |
| +0.59% | -0.41% | +67.38% | +112.51% | 35.52B | |
| -0.65% | -0.86% | -3.18% | +38.37% | 12.07B | |
| +1.32% | +1.15% | +32.83% | +126.50% | 9.29B | |
| -1.76% | -4.19% | +41.36% | -6.88% | 6.92B | |
| +0.33% | +0.42% | +19.54% | +38.03% | 7B | |
| -0.44% | +0.89% | +3.74% | +225.64% | 6.74B | |
| +6.39% | +7.36% | -16.52% | +20.63% | 6.36B | |
| -0.00% | +4.41% | +23.88% | +140.92% | 4.48B | |
| Average | +0.55% | +1.75% | +20.29% | +86.82% | 14.9B | |
| Weighted average by Cap. | +0.32% | +1.33% | +27.19% | +88.39% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 307B 3.19B 2.79B 2.57B 2.36B 4.48B 4.55B 30.69B 12.04B 150B 11.97B 11.71B 517B | 336B 3.49B 3.05B 2.81B 2.59B 4.9B 4.98B 33.57B 13.17B 164B 13.09B 12.81B 565B |
| Net income | 42.37B 440M 385M 355M 326M 619M 629M 4.24B 1.66B 20.71B 1.65B 1.62B 71.38B | 49.06B 510M 446M 411M 378M 716M 728M 4.91B 1.93B 23.98B 1.91B 1.87B 82.65B |
| Net Debt | 83.85B 871M 762M 703M 646M 1.22B 1.25B 8.39B 3.29B 40.98B 3.27B 3.2B 141B | 44.3B 460M 403M 371M 341M 647M 658M 4.43B 1.74B 21.65B 1.73B 1.69B 74.63B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 16/07/26 | INR 1,155.40 | -0.13% | 931,567 |
| 15/07/26 | INR 1,156.90 | +2.06% | 2,033,795 |
| 14/07/26 | INR 1,133.60 | +0.20% | 1,125,219 |
| 13/07/26 | INR 1,131.30 | -1.69% | 1,514,991 |
| 10/07/26 | INR 1,150.80 | -0.71% | 824,192 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ZYDUSLIFE Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition